Awareness of prostate health is alarmingly low in men over 50, a new survey1 commissioned by the European Association of Urology (EAU) has revealed, despite the fact that at the age of 60 and over, 40 percent of men suffer from an enlarged prostate. The survey, which assessed knowledge of the prostate in 3,010 men […]
There is scant information about intermediate / long-term comparative outcomes between robot assisted radical cystectomy (RARC) and open radical cystectomy (ORC). The purpose of this study is to present survival and oncological outcomes between bladder cancer patients who undergo RARC vs.
Erectile dysfunction (ED) is prevalent in middle-aged and older men and can significantly decrease their quality of life. The incidence of ED increased by aging, smoking, metabolic syndrome, lifestyle diseases, and mental status. Decreased physical activity is also known as the risk factor of ED. The benefits of aerobic exercise with a treadmill or bicycle […]
On behalf of the Young Academic Urologists (YAU) Kidney Cancer working group of the European Urological Association (EAU), a systematic review and quantitative synthesis of the impact of suture techniques during laparoscopic and robot-assisted partial nephrectomy was recently published in the British Journal of Urology International.1 Interesting findings of the study included that running suture, […]
San Francisco, CA (UroToday.com) — Members of the prostate cancer community are invited to shine a light on the deadly disease during the first-ever ZERO Cancer Day. ZERO – The End of Prostate Cancer1 is hosting this one-day-only special event to recognize the passion of prostate cancer survivors, patients, and their families. On ZERO Cancer […]
There is no contemporary proof of cancer-control benefits in octogenarian clinically localized prostate cancer (PCa) patients with life expectancy (LE) < 10 years. Therefore, cancer-specific mortality (CSM) rates after external beam radiation therapy (EBRT) vs. no local treatment (NLT) were tested in octogenarian PCa patients with LE < 10 years. Within the surveillance, epidemiology, and end results database (2004-2015), we identified […]
Creatine supplementation has consistently been demonstrated to augment adaptations in body composition, muscle strength and physical function in a variety of apparently healthy older adults and clinical populations. The effects of creatine supplementation and resistance training in individuals with cancer have yet to be investigated. This study aims to examine the effects of creatine supplementation […]
The interpretation of the presence of AR-V7 in circulating tumour cells (CTCs) in men with metastatic castration-resistant prostate cancer (mCRPC) remains to be elucidated. AR-V7 may hold promise as a predictive biomarker, but there may be prognostic impact of AR-V7 positivity as well. To investigate the clinical value of AR-V7, we determined whether AR-V7 detection […]
The objective of this overview was to critically evaluate the effect of polyethylene glycol (PEG)-based hydrogel spacers during prostate brachytherapy with regard to dosimetric and clinical benefits, as well as procedure-related toxicity. A systematic search in the PubMed database was performed. A total of 12 studies, involving 615 patients with PEG hydrogel injection, were included. […]
Technical advancement and availability of high-throughput analysis has advanced molecular subtyping of most cancers. Thus, new possibilities for precision oncology have emerged. Therefore, we aimed to collect data regarding availability and use of next generation sequencing (NGS) for urothelial cancer within the uropathology working group of the German Society of Pathology. We collected data by […]
